{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:16:07Z","timestamp":1779297367390,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.12.624","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T18:02:07Z","timestamp":1482170527000},"page":"405-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Frederick L.","family":"Locke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irwin","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Light","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Beato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginna G.","family":"Laport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auayporn","family":"Nademanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Socie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.12.624_bib0010","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2004-03-0854","article-title":"Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial","volume":"104","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V95.1.83","article-title":"Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease","volume":"95","author":"Przepiorka","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0020","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1365-2141.2001.02582.x","article-title":"Treatment of steroid-refractory acute and chronic graft-versus-host disease with daclizumab","volume":"112","author":"Willenbacher","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2004.04856.x","article-title":"Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis","volume":"124","author":"Srinivasan","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bmt.1704929","article-title":"Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept","volume":"35","author":"Wolff","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2141.2006.06321.x","article-title":"Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease","volume":"135","author":"Bordigoni","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1705762","article-title":"Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease","volume":"40","author":"Perales","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1399-3046.2008.00959.x","article-title":"Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease","volume":"13","author":"Schechter","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bmt.2008.331","article-title":"Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience","volume":"43","author":"Miano","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14712598.6.4.315","article-title":"T regulatory cells as an immunotherapy for transplantation","volume":"6","author":"Albert","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-065X.2008.00634.x","article-title":"CD4+ T-regulatory cells: toward therapy for human diseases","volume":"223","author":"Allan","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2004-01-0151","article-title":"In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures","volume":"104","author":"Godfrey","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2006.04.009","article-title":"Role of naturally arising regulatory T cells in hematopoietic cell transplantation","volume":"12","author":"Nguyen","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0100","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2016.12.624_bib0105","first-page":"621a","article-title":"A phase II\/III randomized, double-blind, placebo-controlled multicentre trial of humanized anti-Tac for prevention of acute graft-versus-host disease in recipients of marrow transplants from unrelated donors","volume":"86","author":"Anasetti","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2016.12.624_bib0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/stem.5530040710","article-title":"Acute and chronic graft-versus-host disease in man","volume":"4","author":"Sullivan","year":"1986","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0120","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"1980"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0130","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3324\/haematol.2012.067140","article-title":"A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation","volume":"97","author":"Pidala","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0135","doi-asserted-by":"crossref","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0140","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.176.6.3301","article-title":"Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells","volume":"176","author":"Kohm","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0145","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1073\/pnas.1009220107","article-title":"Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation","volume":"107","author":"M\u00fcller","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0150","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.174.5.3051","article-title":"Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease","volume":"174","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0155","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1172\/JCI25463","article-title":"Control of homeostatic proliferation by regulatory T cells","volume":"115","author":"Shen","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0160","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0170","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0175","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0180","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0185","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0190","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0195","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1182\/blood-2011-10-386482","article-title":"Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer","volume":"119","author":"Yao","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0200","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0205","first-page":"3128","article-title":"Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody","volume":"59","author":"Onizuka","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0210","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1158\/1078-0432.CCR-15-0767","article-title":"Identification of CD25 as STAT5-dependent growth regulator of leukemic stem cells in Ph+ CML","volume":"22","author":"Sadovnik","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0215","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbmt.2004.04.002","article-title":"Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation","volume":"10","author":"Martin","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0220","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1182\/blood-2010-12-326108","article-title":"Depletion of CD25+ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma","volume":"117","author":"Jing","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0225","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.bbmt.2012.11.074","article-title":"CD25+ regulatory T cell-depleted donor lymphocyte infusion for relapse after allogeneic transplantation: a PHASE 1 study","volume":"19","author":"Nikiforow","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0230","doi-asserted-by":"crossref","first-page":"41ra52","DOI":"10.1126\/scitranslmed.3001302","article-title":"CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation","volume":"2","author":"Maury","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2016.12.624_bib0235","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(12)62190-4","article-title":"Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial","volume":"381","author":"Gold","year":"2013","journal-title":"Lancet"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:24Z","timestamp":1761058704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116311831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116311831"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.624","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of the American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}